Capital expenditure decreased 51.4%
Capital expenditure changed -51.4% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -51.4% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
Cash & equivalents changed +151.9% from the comparable as-filed period.
Free-cash-flow proxy changed -141.6% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Net income changed -34.5% from the comparable as-filed period.
Operating cash flow changed -142.2% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Operating income changed -25.8% from the comparable as-filed period.
Operating margin changed -3637 basis points from the comparable as-filed period.
Stock-based compensation changed +55.0% from the comparable as-filed period.
Revenue changed -8.0% from the comparable as-filed period.
Capex / revenue changed -6 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.